HU-345

From Wikipedia, the free encyclopedia
Jump to: navigation, search
HU-345
HU-345 molecular structure.png
Systematic (IUPAC) name
6,6,9-trimethyl-3-pentyl-1H-benzo[c]chromene-1,4(6H)-dione
Clinical data
Legal status
?
Identifiers
CAS number  YesY
ATC code ?
PubChem CID 11198119
ChemSpider 9373188 YesY
ChEMBL CHEMBL127671 YesY
Chemical data
Formula C21H24O3 
Mol. mass 324.414
 YesY (what is this?)  (verify)

HU-345 (cannabinol quinone) is a drug that is able to inhibit aortic ring angiogenesis more potently than its parent compound cannabinol.[1][2]

See also[edit]

References[edit]

  1. ^ Natalya M. Kogan, et al. (2006). "A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells". Molecular Pharmacology 70 (1): 51–59. doi:10.1124/mol.105.021089. PMID 16571653. 
  2. ^ US patent 0092584, Mechoulam R, Kogan NM, Rabinowitz R, Schlesinger M, "Therapeutic Use of Quinonoid Derivatives of Cannabinoids", granted 2011-04-21